Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|July 12, 2019
A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated MacrophagesHiromi Watanabe, Kadoaki Ohashi, Kazuya Nishii, et al.
Cancer Science|September 4, 2014
oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survivalManabu Fujisawa, Keisuke Seike, Kouta Fukumoto, et al.
Acta Medica Okayama|April 30, 2024
Sigle Agent of Posttransplant Cyclophosphamide Without Calcineurin Inhibitor Controls Severity of Experimental Chronic GVHDKyosuke Saeki, Hideaki Fujiwara, Keisuke Seike, et al.
The Journal of Biological Chemistry|November 22, 2021
A redox cycle with complex II prioritizes sulfide quinone oxidoreductase-dependent H2S oxidationRoshan Kumar, Aaron P Landry, Arkajit Guha, et al.
Internal Medicine (Tokyo, Japan)|July 17, 2024
Simulation-based Bone Marrow Aspiration and Trephine Biopsy Education for Medical Students: A Non-randomized Controlled TrialAkira Yamamoto, Hisakazu Nishimori, Keisuke Seike, et al.
The Journal of Clinical Investigation|December 15, 2025
Mitochondrial complex II orchestrates divergent effects in CD4+ and CD8+ T cellsKeisuke Seike, Shih-Chun A Chu, Yuichi Sumii, et al.
Blood Cell Therapy|December 10, 2025
Feasibility of early tacrolimus initiation in haploidentical-PBSCT with post-transplant cyclophosphamide after melphalan-based conditioning regimenWataru Kitamura, Toshiki Terao, Ken-Ichi Matsuoka, et al.
Acta Medica Okayama|December 24, 2025
Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab ProphylaxisMoe Hagihara, Keisuke Seike, Kenta Hayashino, et al.
Iscience|August 31, 2022
Rearrangement of T Cell genome architecture regulates GVHDYaping Sun, Gabrielle A Dotson, Lindsey A Muir, et al.
International Journal of Hematology|September 22, 2018
Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantationMakoto Nakamura, Nobuharu Fujii, Kazuyoshi Shimizu, et al.
Pageof 4